InvestorsHub Logo
Followers 14
Posts 603
Boards Moderated 0
Alias Born 12/27/2017

Re: Rdunn88 post# 251702

Monday, 12/17/2018 3:42:14 PM

Monday, December 17, 2018 3:42:14 PM

Post# of 403658
I don't believe this to be the case actually...

They still have options, but the concern is Leo's seeming inability to comprehend time (in addition to being able to close a deal of any sort).

If they license a product for a specific indication, that's worth money. That's possibly one of the faster means of realizing a revenue stream (and what I'd do to fund the progression of other considerations on the table).

If they partner and then take on cash upfront and write in royalty payments, depending on how quickly they can complete the P3 and get approval to take a product to market, there's an opportunity there as well to salvage.

Time is of the essence here. They just burned up literally an entire year with zero results of the public-facing-partnership-variety. That's a problem. The SP reflects this. Market-confidence reflects this.

No RS required really. IF they can get SP up (organically through a partnership/license) then they'll be ok.

There was talk of doing this organically with 'clinics' and a direct-marketing opportunity they'd identified once they'd got to P3. I don't understand the intricacies of the setup, but I see it as being a stretch. They're also not allowing for their burn-rate. I don't understand their in-house strategy whatsoever, and it doesn't seem to account for things like time and overhead. (strange, right?)

They're looking at further dilution just to get there with the MFO. Once they hit a certain point (assuming they're able to), then Aspire could come back into the picture (not sure how that was left)...

RS is the absolute LAST thing we want to see. Period (aside from the office burning to the ground of course).

They will have to do a RS with or without a partner. Nobody is going to partner the way IPIX is setup with staff and financials. No chance in hell... The for-sale sign just got bigger after P's funeral.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News